Verified email-pattern data for Inkocell Therapeutics is currently limited. You can still use the company insights and contact sections below.
In a nutshell, heart failure is a leading cause of death in Switzerland, responsible for 12% of deaths each year. Nearly half of all heart failure deaths can be attributed to cardiac fibrosis. Cardiac fibrosis is a build-up of scar tissue in the heart as a result of stress or damage. This dramatically impairs how the heart works and how efficiently it can pump blood.
At the moment, there is no cure for cardiac fibrosis – the condition can only be managed through pain management drugs and beta blockers. These are costly, inconvenient, and don’t provide a cure. Inkocell has developed a new therapy which we believe will cure cardiac fibrosis through a single injection.
Why is our technology important? We have developed the first cure for cardiac fibrosis. We are using Natural Killer (NK) cells – a type of cell that plays a crucial role in identifying and destroying infected or abnormal cells in the body. We have adapted and engineered the NK cells to target active fibroblasts (the cells that produce the cardiac scarring). As the technology targets the problem cells directly, we believe that the treatment will be complete with a single shot. Our approach reduces side effects and promotes regeneration of the heart muscle to restore normal heart function.
The benefits of our solution Inkocell is creating a new standard of medical care. Their treatment allows the heart to regenerate and recover its initial function. This means incessant and cumbersome treatment is a thing of the past. With our engineered NK call technology, we are offering a one-step cure for lasting health.
In vitro results show the treatment is:
• safer, with low side effects
• targeted, only eliminating activated fibroblasts
• efficient, with a high killing rate
Company Details
- Employees
- 2
- Industry
- Pharmaceutical Manufacturing
Inkocell Therapeutics Questions
Inkocell Therapeutics's LinkedIn profile is https://www.linkedin.com/company/inkocell-therapeutics
Inkocell Therapeutics has
2 employees.
View email and phone details for 2
employees at Inkocell Therapeutics.
Inkocell Therapeutics's industry is
Pharmaceutical Manufacturing
Inkocell Therapeutics's top competitors are
Azurecell,
Noovi Ag,
Herosupport Sa,
Bioscibex,
Aseptuva,
Cellx Biosolutions,
Orthosens,
Envisionit Deep Ai®,
Molesense,
Luxtelligence.
Inkocell Therapeutics's categories are Pharmaceutical Manufacturing
Explore related pages
Related company profiles:
Companies like Inkocell Therapeutics
Top Inkocell Therapeutics Employees
-
Angela Madurga Alonso
Sciencepreneur, Phd | Car Nk & Car T…
Switzerland, Switzerland -
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.